Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Aleem Gangjee

7PUBLICATIONS

19CO-AUTHORS

Cancer geneticsCheminformatics and quantitative structure-activity relationshipsPharmacogenomicsBiologically active molecules

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Feb 20, 2024

Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer.

Adrianne Wallace-Povirk, Carrie O'Connor, Aamod S Dekhne

|Feb 07, 2024

Structural Characterization of 5-Substituted Pyrrolo[3,2-<i>d</i>]pyrimidine Antifolate Inhibitors in Complex with Human Serine Hydroxymethyl Transferase 2.

Jade M Katinas, Md Junayed Nayeen, Mathew Schneider

|Dec 20, 2023

Discovery of Tumor-Targeted 6-Methyl Substituted Pemetrexed and Related Antifolates with Selective Loss of RFC Transport.

Krishna Kaku, Manasa P Ravindra, Nian Tong

|Aug 15, 2023

Structure-Based Design of Transport-Specific Multitargeted One-Carbon Metabolism Inhibitors in Cytosol and Mitochondria.

Md Junayed Nayeen, Jade M Katinas, Tejashree Magdum

|May 18, 2023

Multitargeted 6-Substituted Thieno[2,3-<i>d</i>]pyrimidines as Folate Receptor-Selective Anticancer Agents that Inhibit Cytosolic and Mitochondrial One-Carbon Metabolism.

Nian Tong, Jennifer Wong-Roushar, Adrianne Wallace-Povirk

|Apr 28, 2018

Fluorine-Substituted Pyrrolo[2,3- d]Pyrimidine Analogues with Tumor Targeting via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis.

Manasa Ravindra, Mike R Wilson, Nian Tong

Pageof 2

Frequent Collaborators

4 joint publications

Zhanjun Hou

4 joint publications

Larry H Matherly

2 joint publications

Adrianne Wallace-Povirk

2 joint publications

Charles E Dann

1 joint publications

Nian Tong

1 joint publications

Yesha Shah

1 joint publications

Tejashree Magdum

1 joint publications

Krishna Kaku

1 joint publications

Carrie O'Connor

1 joint publications

Aamod S Dekhne

Frequent Collaborators

4 joint publications

Zhanjun Hou

4 joint publications

Larry H Matherly

2 joint publications

Adrianne Wallace-Povirk

2 joint publications

Charles E Dann

Top Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on : May 09, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

See more related videos

Top Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on : May 09, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

See more related videos